T-cell acute lymphoblastic leukaemia (T-cell ALL) is an aggressive blood cancer that develops when too many abnormal T-cells are produced in the bone marrow, overwhelming the body’s ability to fight infections and make healthy blood cells.

Understanding T-cell Acute Lymphoblastic Leukaemia

T-cell acute lymphoblastic leukaemia, commonly known as T-cell ALL or T-ALL, is an uncommon but fast-growing type of blood cancer. It affects a specific type of white blood cell called T-lymphocytes, which are cells that normally help the body fight off infections by killing germs and supporting other immune cells. In T-cell ALL, these cells become immature and abnormally shaped during their development. These abnormal cells are sometimes called blasts or leukaemia cells, and they do not work properly to fight infections.^[1]

The disease starts in the bone marrow, the soft, spongy tissue inside bones where blood cells are made. As these immature T-cells multiply rapidly, they crowd out the bone marrow, preventing it from producing enough healthy red blood cells, normal white blood cells, and platelets (cells that help blood to clot). This overwhelming number of leukaemia cells causes many of the symptoms people experience.^[1]

T-cell ALL is considered more aggressive than its counterpart, B-cell acute lymphoblastic leukaemia. The word “acute” means the disease progresses quickly and can worsen rapidly if not treated. T-cells from the bone marrow normally travel to the thymus, a small organ located behind the breastbone. In T-ALL, these cells undergo abnormal changes within the thymus and become cancerous during this developmental stage.^[2][11]

Who Gets T-cell ALL: Epidemiology

T-cell ALL represents approximately 12% to 15% of all newly diagnosed acute lymphoblastic leukaemia cases in children and up to 25% in adults. Interestingly, the disease is more common in adults compared to children, although its occurrence decreases as people get older. Among children with acute lymphoblastic leukaemia, T-ALL accounts for about 15% of cases, while in adults, it makes up roughly 25% of cases.^[1][2]

The disease shows particular patterns in different age groups. In children, there is a peak incidence between about 2 to 5 years of age. Among children diagnosed with T-ALL, the median age of onset is around 9 years, and the disease is particularly prominent among adolescents. For adults, the median age of onset occurs around 30 years.^[2][11]

T-cell ALL affects slightly more males than females across all age groups. Among very young children under age 1, girls are at higher risk than boys. However, after age 1, the risk becomes higher for males and remains so throughout life.^[1][6]

Overall, acute lymphoblastic leukaemia makes up less than 1% of all cancers in the United States, with T-cell ALL being a less common subtype. Despite being a relatively rare disease, it is the most common type of cancer in children, though T-cell ALL specifically represents a smaller proportion of these childhood cases.^[6]

Causes of T-cell ALL

The exact cause of T-cell ALL is not fully understood, but scientists know that the disease arises from changes in genetic material. These changes, called mutations, happen in the DNA of bone marrow cells. DNA contains the instructions that tell each cell what to do, including when to grow, divide, and die. When these instructions become damaged or altered, cells can start to grow uncontrollably and become cancerous.^[1][3]

In T-cell ALL, certain genetic and cytogenetic (chromosome-related) abnormalities disrupt the normal pathways that control how T-cells develop in the thymus. These disruptions affect tumour suppressor genes (genes that normally prevent cancer) and the control of cell growth and multiplication. Between 60% and 80% of patients who develop T-cell ALL have abnormal changes in their chromosomes and genes. These are acquired mutations, meaning they develop during a person’s lifetime and cannot be passed on to their children. The remaining patients do not have any detectable chromosome or mutation abnormalities.^[1][4]

Young children with T-ALL may have had these gene changes happen before they were born, during fetal development. In adults, the disease may be linked to certain exposures. For instance, previous chemotherapy or exposure to radiation may increase the risk of developing acute lymphoblastic leukaemia, including the T-cell type. In adults, exposure to certain harmful substances called carcinogens, including tobacco, has been linked to the disease.^[6][10]

Risk Factors for T-cell ALL

While many people wonder what puts someone at higher risk for T-cell ALL, it’s important to understand that having a risk factor does not mean someone will definitely develop the disease. Many people with risk factors never get T-cell ALL, and some people with no known risk factors do develop it. Risk factors are simply characteristics or exposures that increase the chance, but do not directly cause cancer on their own.^[10]

Age plays a role in T-cell ALL risk. Children under 15 years and adults over 50 years face the highest risk. Among children, the peak risk occurs between ages 2 and 5, while in adolescents and young adults, the median onset is around age 9.^[6]

Certain genetic conditions can raise the risk of developing T-ALL. People with conditions such as Down syndrome or Fanconi anaemia have a higher chance of developing acute lymphoblastic leukaemia. A family history of leukaemia, especially among siblings, also increases risk.^[6][11]

Radiation exposure is another known risk factor. This includes exposure to radiation during fetal development (while a baby is still in the womb) or previous radiation therapy for another medical condition. Chemical exposure, particularly previous chemotherapy treatment for another cancer, can also increase the likelihood of developing T-cell ALL.^[6][10]

Certain viral infections may raise the risk of acute lymphoblastic leukaemia. Infections like Epstein-Barr virus and human T-cell leukaemia virus have been associated with increased risk, though these viruses are different from adult T-cell leukaemia/lymphoma, which is a separate condition.^[6]

Race and ethnicity also show patterns in T-ALL occurrence. People who are white have a slightly higher risk compared to other racial and ethnic groups.^[6]

Symptoms of T-cell ALL

At first, the symptoms of T-cell ALL can be vague and easily mistaken for other common illnesses, such as the flu. This can make early recognition challenging. Sometimes, a routine blood test will reveal signs of the disease, such as unusually high levels of white blood cells, before symptoms become noticeable. However, the majority of patients do have symptoms when they are diagnosed.^[1]

The symptoms arise primarily because the large numbers of abnormal T-cells overwhelm the bone marrow. This prevents the bone marrow from producing adequate numbers of red blood cells, platelets, and normal white blood cells. Each type of blood cell has an important job, so when their numbers drop, specific problems occur.^[1]

When red blood cell levels fall, people develop anaemia, which causes weakness, extreme tiredness, pale skin, difficulty breathing, lightheadedness, and heart palpitations. Because there aren’t enough normal white blood cells to fight germs, people experience frequent infections, unexplained fevers, chills, and night sweats. Low platelet counts lead to easy bruising, bleeding gums, frequent or severe nosebleeds, and tiny red or purple spots on the skin called petechiae. Petechiae are flat spots, about 2 mm in size, that do not disappear when pressed beneath a glass. People may also develop larger purple-coloured patches called purpura, which, unlike regular bruises, are not caused by injury.^[1][2]

In T-cell ALL specifically, patients often present with extremely high white blood cell counts. Swollen lymph nodes can appear in the neck, armpits, or other areas of the body. Because T-ALL frequently creates masses in the thymus (behind the breastbone), some people develop swelling in the middle of the chest. This can cause facial swelling, difficulty breathing, or shortness of breath.^[1][2]

Other common symptoms include unexpected weight loss, loss of appetite, joint pain, and swelling of the lymph nodes. When the disease spreads to the liver or spleen, these organs can become enlarged, causing abdominal pain. If leukaemia cells enter the central nervous system, symptoms might include headaches, nausea and vomiting, balance problems, blurred or double vision, facial muscle weakness or numbness, and seizures.^[2][6][11]

It’s important to remember that many of these symptoms can be caused by other, less serious conditions. However, anyone experiencing persistent symptoms lasting longer than two weeks should speak with a healthcare provider for proper evaluation.^[6]

Prevention of T-cell ALL

Unlike some other diseases, there are no specific lifestyle changes, vaccinations, or supplements known to prevent T-cell ALL. Because the exact cause of the disease is not fully understood, and many cases arise from genetic changes that happen spontaneously or before birth, prevention strategies are limited.^[1]

However, understanding risk factors can help people make informed decisions. For adults, avoiding tobacco use may reduce overall cancer risk, as tobacco exposure has been linked to acute lymphoblastic leukaemia. Limiting unnecessary exposure to radiation, especially during pregnancy, may also be prudent, though most radiation exposure from medical imaging is carefully controlled and considered safe when medically necessary.^[6][10]

For people with genetic conditions known to increase leukaemia risk, such as Down syndrome or Fanconi anaemia, awareness and regular medical monitoring may help with early detection if the disease develops, though it does not prevent it. People with a family history of leukaemia, particularly siblings of those affected, should discuss their concerns with healthcare providers.^[6][11]

Currently, there are no screening tests recommended for T-cell ALL in the general population or even in high-risk groups, as the disease is relatively rare. Early detection typically happens when symptoms prompt medical evaluation, or occasionally when routine blood tests reveal abnormalities.^[1]

How the Body Changes in T-cell ALL: Pathophysiology

Understanding what happens inside the body during T-cell ALL helps explain why symptoms occur and how the disease progresses. The disease fundamentally disrupts the normal process of blood cell production and immune system function.^[4]

Normally, the bone marrow produces blood stem cells, which are immature cells that can develop into different types of blood cells. These stem cells go through several stages of development. Some become lymphoid stem cells, which then develop into lymphoblasts, and finally mature into different types of lymphocytes: B-lymphocytes, T-lymphocytes, or natural killer cells. Each type has a specific role in protecting the body from infection.^[3]

In T-cell ALL, something goes wrong during this development process. The cells that should become mature, functioning T-lymphocytes instead become stuck at an immature stage and begin multiplying uncontrollably. These immature cells accumulate in enormous numbers in the bone marrow. Because the bone marrow has limited space, as these leukaemia cells increase, there is less room for the production of healthy red blood cells, normal white blood cells, and platelets.^[3]

The genetic and molecular abnormalities in T-ALL affect several critical cellular pathways. Specific genes are frequently mutated in T-cell ALL patients. Up to 80% of patients have a deletion of the CDKN2A gene, and 60% have deletions of the TAL1 gene. The most common mutations occur in the NOTCH1/FBXW7 pathway, found in about 60% of adult patients. Only two genes, NOTCH1 and CDKN2A/2B, are mutated in more than 50% of T-ALL cases, with many other genes mutated at lower frequencies.^[1]

These genetic changes disrupt the developmental pathways that control how T-cells mature in the thymus. They also affect tumour suppressor genes, which normally prevent cells from becoming cancerous. Additionally, the control mechanisms that regulate cell growth and multiplication become dysregulated, allowing cells to divide endlessly without the normal checkpoints that would stop this process.^[4]

As leukaemia cells multiply in the bone marrow, they begin to spill over into the bloodstream. From there, they can travel throughout the body and accumulate in various organs. T-cell ALL frequently spreads to the lymph nodes, liver, and spleen, causing these organs to enlarge. The disease has a particular tendency to infiltrate the central nervous system, affecting the brain and spinal cord in about 10% of patients at diagnosis. The accumulation of leukaemia cells in the thymus creates masses in the chest (mediastinal masses) in approximately 75% of cases.^[1][11]

One notable feature of T-cell ALL is hyperleukocytosis, meaning patients often present with extremely high white blood cell counts. These high numbers of abnormal cells in the bloodstream can cause complications by making the blood thicker and potentially blocking small blood vessels in various organs.^[1]

Because the leukaemia cells don’t function properly as immune cells, patients become immunocompromised, meaning their immune system cannot fight infections effectively. This leaves them vulnerable to frequent and serious infections, even from organisms that would not normally cause problems in healthy people.^[2]